ADIPOQ and cancer: The impact of ET on AMPK via the modulation of adiponectin levels has been shown to inhibit PCa viability in prostate (PC-3) cancer cells [187], but, intriguingly, it increases PCa cancer cell migration and the metastatic potential of human PCa cells [188].